×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
Senology / Breast / Webinar
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
16140 views

Programme

18:00
Pourquoi les chirurgiens doivent favoriser les traitements néo-adjuvants ?
Pr Fabien Reyal
 
18:20
Prise en charge des patientes métastatiques synchrones
Pr Jean-Yves Pierga
18:40 Prise en charge des récidives régionales isolées
Dr Sarah Differding
 
19:00 Débat/discussion - Réponses aux questions

 
Réunion modérée par Pr Fabien Reyal

Shooting date : 2021-04-14
Last update : 2022-12-19
Jean-Yves Pierga
Paris, France
Private message
Sarah Differding
Paris, France
Private message
Fabien Reyal
Paris, France
Private message

Cancer breast

1 Videos / Public /

Share
Discover playlist

Sein

10 Videos / Public /

Share
Discover playlist

Videos a voir

9 Videos / Public /

Share
Discover playlist
2 comments
Join the Discussion
  • Delphine M.

    Delphine M. Oui je suis là!!!

    2021-04-14, 19h31
      Join files
      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Kheloudja B.

      Kheloudja B. les tumeurs de 2 cm ou plus HER2 surexprimé , reçoivent une chimiothérapie néoadjuavnte et si pas de yp0yPn0 , du TDM 1 en adjuvant . que disent les données sur les tumemeurs HER2+ qui ne reçoivent de néoadj car petites de taille qui au final recevront herception en adjuvant mais ne connaissant pas leur sensibilité au néoadj , est ce que celles qui n'auraient pas répondu ne rateraient pas le bénéfice du TDM1 en adjuvant , pourquoi pas du néoadj pour toutes lees HER2+?

      2021-05-16, 23h12
        Join files
        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
      Honolulu : Thursday, October 14th 2021 from 07am to 08am (GMT+2)
      San Francisco : Thursday, October 14th 2021 from 10am to 11am (GMT+2)
      New York : Thursday, October 14th 2021 from 01pm to 02pm (GMT+2)
      Buenos Aires : Thursday, October 14th 2021 from 02pm to 03pm (GMT+2)
      Reykjavik : Thursday, October 14th 2021 from 05pm to 06pm (GMT+2)
      London / Dublin : Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
      Paris / Berlin : Thursday, October 14th 2021 from 07pm to 08pm (GMT+2)
      Istanbul : Thursday, October 14th 2021 from 08pm to 09pm (GMT+2)
      Moscou / Dubaï : Thursday, October 14th 2021 from 09pm to 10pm (GMT+2)
      Bangkok : Friday, October 15th 2021 from 12am to 01am (GMT+2)
      Shanghai : Friday, October 15th 2021 from 01am to 02am (GMT+2)
      Tokyo : Friday, October 15th 2021 from 02am to 03am (GMT+2)
      Sydney : Friday, October 15th 2021 from 04am to 05am (GMT+2)
      Wellington : Friday, October 15th 2021 from 06am to 07am (GMT+2)

      Le cancer du sein métastatique HER2 +, standards actuels et orientations futures

      Octobre Rose 2021

      Senology / Breast / Webinar
      View more
      Share
      Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
      Honolulu : Tuesday, December 21st 2021 from 07am to 08:30am (GMT+1)
      San Francisco : Tuesday, December 21st 2021 from 09am to 10:30am (GMT+1)
      New York : Tuesday, December 21st 2021 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Tuesday, December 21st 2021 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Tuesday, December 21st 2021 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
      Istanbul : Tuesday, December 21st 2021 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Tuesday, December 21st 2021 from 09pm to 10:30pm (GMT+1)
      Bangkok : Wednesday, December 22nd 2021 from 12am to 01:30am (GMT+1)
      Shanghai : Wednesday, December 22nd 2021 from 01am to 02:30am (GMT+1)
      Tokyo : Wednesday, December 22nd 2021 from 02am to 03:30am (GMT+1)
      Sydney : Wednesday, December 22nd 2021 from 03am to 04:30am (GMT+1)
      Wellington : Wednesday, December 22nd 2021 from 05am to 06:30am (GMT+1)

      Indication de chimiothérapie néoadjuvante dans la prise en charge des patientes atteintes d’un c...

      Senology / Breast / Webinar/1 Comments
      View more
      Share
      Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Thursday, February 1st 2024 from 07am to 08:30am (GMT+1)
      San Francisco : Thursday, February 1st 2024 from 09am to 10:30am (GMT+1)
      New York : Thursday, February 1st 2024 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Thursday, February 1st 2024 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Thursday, February 1st 2024 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
      Istanbul : Thursday, February 1st 2024 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Thursday, February 1st 2024 from 09pm to 10:30pm (GMT+1)
      Bangkok : Friday, February 2nd 2024 from 12am to 01:30am (GMT+1)
      Shanghai : Friday, February 2nd 2024 from 01am to 02:30am (GMT+1)
      Tokyo : Friday, February 2nd 2024 from 02am to 03:30am (GMT+1)
      Sydney : Friday, February 2nd 2024 from 03am to 04:30am (GMT+1)
      Wellington : Friday, February 2nd 2024 from 05am to 06:30am (GMT+1)

      Prise en charge du cancer du sein métastatique HER2-faible

      Cycle d'enseignement - Le cancer du sein

      Senology / Breast / Webinar
      View more
      Share
      Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Wednesday, March 13th 2024 from 07am to 08:30am (GMT+1)
      San Francisco : Wednesday, March 13th 2024 from 09am to 10:30am (GMT+1)
      New York : Wednesday, March 13th 2024 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Wednesday, March 13th 2024 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Wednesday, March 13th 2024 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
      Istanbul : Wednesday, March 13th 2024 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Wednesday, March 13th 2024 from 09pm to 10:30pm (GMT+1)
      Bangkok : Thursday, March 14th 2024 from 12am to 01:30am (GMT+1)
      Shanghai : Thursday, March 14th 2024 from 01am to 02:30am (GMT+1)
      Tokyo : Thursday, March 14th 2024 from 02am to 03:30am (GMT+1)
      Sydney : Thursday, March 14th 2024 from 03am to 04:30am (GMT+1)
      Wellington : Thursday, March 14th 2024 from 05am to 06:30am (GMT+1)

      Prise en charge du cancer HER2+ métastatique

      Cycle d'enseignement - Le cancer du sein

      Senology / Breast / Webinar
      View more
      Share
      Scroll Up